Search

everythinglearnresearchcommunity

for

Search:↓

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Hair loss can cause significant social and emotional issues, especially for women and young men.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Different hair loss types need accurate diagnosis for proper treatment.

Pharmacists play a crucial role in patient care and education.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

PCOS is caused by both genetics and environmental factors like diet and obesity.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Androgens can help prevent memory problems caused by apoE4.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.